{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T15:47:45Z","timestamp":1775058465859,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,19]]},"DOI":"10.7759\/cureus.84440","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:01:51Z","timestamp":1747731711000},"source":"Crossref","is-referenced-by-count":3,"title":["Surgery Versus Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer (NSCLC): A Comprehensive Review of Survival and Local Control Outcomes"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Bin Sumaida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandan M","family":"Shanbhag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Pervez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalifa","family":"AlKaabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Balaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102693","article-title":"Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN","volume":"93","author":"Zhou J","year":"2024","unstructured":"Zhou J, Xu Y, Liu J, Feng L, Yu J, Chen D. Global burden of lung cancer in 2022 and projections to 2050: incidence and mortality estimates from GLOBOCAN. Cancer Epidemiol. 2024, 93:102693. 10.1016\/j.canep.2024.102693","journal-title":"Cancer Epidemiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment","volume":"94","author":"Duma N","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019, 94:1623-40. 10.1016\/j.mayocp.2019.01.013","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.9","article-title":"Non-small-cell lung cancer","volume":"1","author":"Gridelli C","year":"2015","unstructured":"Gridelli C, Rossi A, Carbone DP, et al.. Non-small-cell lung cancer. Nat Rev Dis Primers. 2015, 1:15009. 10.1038\/nrdp.2015.9","journal-title":"Nat Rev Dis Primers"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening","volume":"365","author":"Aberle DR","year":"2011","unstructured":"Aberle DR, Adams AM, Berg CD, et al.. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011, 365:395-409. 10.1056\/NEJMoa1102873","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington JA","year":"2013","unstructured":"Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013, 143:e278S-313S. 10.1378\/chest.12-2359","journal-title":"Chest"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.09.009","article-title":"Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy","volume":"102","author":"Semrau S","year":"2008","unstructured":"Semrau S, Klautke G, Virchow JC, Kundt G, Fietkau R. Impact of comorbidity and age on the outcome of patients with inoperable NSCLC treated with concurrent chemoradiotherapy. Respir Med. 2008, 102:210-8. 10.1016\/j.rmed.2007.09.009","journal-title":"Respir Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2018.09.023","article-title":"Prognostic impact of preoperative comorbidities in geriatric patients with early-stage lung cancer: significance of sublobar resection as a compromise procedure","volume":"125","author":"Yutaka Y","year":"2018","unstructured":"Yutaka Y, Sonobe M, Kawaguchi A, et al.. Prognostic impact of preoperative comorbidities in geriatric patients with early-stage lung cancer: significance of sublobar resection as a compromise procedure. Lung Cancer. 2018, 125:192-7. 10.1016\/j.lungcan.2018.09.023","journal-title":"Lung Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2016.03.14","article-title":"Stereotactic body radiotherapy: current strategies and future development","volume":"8","author":"Tsang MW","year":"2016","unstructured":"Tsang MW. Stereotactic body radiotherapy: current strategies and future development. J Thorac Dis. 2016, 8:S517-27. 10.21037\/jtd.2016.03.14","journal-title":"J Thorac Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic GM","year":"2017","unstructured":"Videtic GM, Donington J, Giuliani M, et al.. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline. Pract Radiat Oncol. 2017, 7:295-301. 10.1016\/j.prro.2017.04.014","journal-title":"Pract Radiat Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2021.04.010","article-title":"Combining stereotactic body radiotherapy and microwave ablation appears safe and feasible for renal cell carcinoma in an early series","volume":"19","author":"Blitzer GC","year":"2021","unstructured":"Blitzer GC, Wojcieszynski A, Abel EJ, et al.. Combining stereotactic body radiotherapy and microwave ablation appears safe and feasible for renal cell carcinoma in an early series. Clin Genitourin Cancer. 2021, 19:e313-8. 10.1016\/j.clgc.2021.04.010","journal-title":"Clin Genitourin Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0150","article-title":"Lung stereotactic body radiotherapy for early-stage NSCLC in patients with prior pneumonectomy: a case report","volume":"12","author":"Simpson DR","year":"2014","unstructured":"Simpson DR, Sanghvi P, Sandhu AP. Lung stereotactic body radiotherapy for early-stage NSCLC in patients with prior pneumonectomy: a case report. J Natl Compr Canc Netw. 2014, 12:1513-6. 10.6004\/jnccn.2014.0150","journal-title":"J Natl Compr Canc Netw"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck FC","year":"2017","unstructured":"Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017, 151:193-203. 10.1016\/j.chest.2016.10.010","journal-title":"Chest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman R","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al.. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010, 303:1070-6. 10.1001\/jama.2010.261","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt026","article-title":"Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis","volume":"24","author":"Verstegen NE","year":"2013","unstructured":"Verstegen NE, Oosterhuis JW, Palma DA, et al.. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol. 2013, 24:1543-8. 10.1093\/annonc\/mdt026","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2014.08.031","article-title":"Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis","volume":"112","author":"Zhang B","year":"2014","unstructured":"Zhang B, Zhu F, Ma X, et al.. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis. Radiother Oncol. 2014, 112:250-5. 10.1016\/j.radonc.2014.08.031","journal-title":"Radiother Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2017.1370519","article-title":"A propensity-matched analysis of outcomes of patients with clinical stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: a meta-analysis","volume":"32","author":"Wen SW","year":"2019","unstructured":"Wen SW, Han L, Lv HL, et al.. A propensity-matched analysis of outcomes of patients with clinical stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: a meta-analysis. J Invest Surg. 2019, 32:27-34. 10.1080\/08941939.2017.1370519","journal-title":"J Invest Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S138701","article-title":"Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Li M","year":"2017","unstructured":"Li M, Yang X, Chen Y, et al.. Stereotactic body radiotherapy or stereotactic ablative radiotherapy versus surgery for patients with T1-3N0M0 non-small cell lung cancer: a systematic review and meta-analysis. Onco Targets Ther. 2017, 10:2885-92. 10.2147\/OTT.S138701","journal-title":"Onco Targets Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments","volume":"14","author":"Lo CK","year":"2014","unstructured":"Lo CK, Mertz D, Loeb M. Newcastle-Ottawa Scale: comparing reviewers' to authors' assessments. BMC Med Res Methodol. 2014, 14:45. 10.1186\/1471-2288-14-45","journal-title":"BMC Med Res Methodol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney JF","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007, 8:16. 10.1186\/1745-6215-8-16","journal-title":"Trials"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2024.107792","article-title":"The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study","volume":"191","author":"de Ruiter JC","year":"2024","unstructured":"de Ruiter JC, van der Noort V, van Diessen JN, Smit EF, Damhuis RA, Hartemink KJ. The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy - a nationwide cohort study. Lung Cancer. 2024, 191:107792. 10.1016\/j.lungcan.2024.107792","journal-title":"Lung Cancer"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol31030116","article-title":"Wedge resection versus stereotactic body radiation therapy for non-small cell lung cancer tumors \u22648 mm","volume":"31","author":"Mansur A","year":"2024","unstructured":"Mansur A, Saleem Z, Beqari J, et al.. Wedge resection versus stereotactic body radiation therapy for non-small cell lung cancer tumors \u22648 mm. Curr Oncol. 2024, 31:1529-42. 10.3390\/curroncol31030116","journal-title":"Curr Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2022.1581","article-title":"Sublobar resection versus stereotactic body radiation therapy for clinical stage i non-small cell lung cancer: a study using data from the Korean Nationwide Lung Cancer Registry","volume":"55","author":"Yun J","year":"2023","unstructured":"Yun J, Cho JH, Hong TH, Yang K, Ahn YC, Kim HK. Sublobar resection versus stereotactic body radiation therapy for clinical stage i non-small cell lung cancer: a study using data from the Korean Nationwide Lung Cancer Registry. Cancer Res Treat. 2023, 55:1171-80. 10.4143\/crt.2022.1581","journal-title":"Cancer Res Treat"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezac118","article-title":"Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer","volume":"62","author":"de Ruiter JC","year":"2022","unstructured":"de Ruiter JC, van Diessen JN, Smit EF, van der Noort V, Damhuis RA, Hartemink KJ. Minimally invasive lobectomy versus stereotactic ablative radiotherapy for stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2022, 62:10.1093\/ejcts\/ezac118","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rrac041","article-title":"Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer","volume":"63","author":"Kishi N","year":"2022","unstructured":"Kishi N, Matsuo Y, Menju T, et al.. Propensity score-based analysis of stereotactic body radiotherapy, lobectomy and sublobar resection for stage I non-small cell lung cancer. J Radiat Res. 2022, 63:758-71. 10.1093\/jrr\/rrac041","journal-title":"J Radiat Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjon.2021.09.052","article-title":"Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: an instrumental variable analysis","volume":"9","author":"Littau MJ","year":"2022","unstructured":"Littau MJ, Freeman R, Vigneswaran WT, Luchette FA, Baker MS, Raad W, Abdelsattar ZM. Comparative effectiveness of stereotactic body radiation therapy versus surgery for stage I lung cancer in otherwise healthy patients: an instrumental variable analysis. JTCVS Open. 2022, 9:249-61. 10.1016\/j.xjon.2021.09.052","journal-title":"JTCVS Open"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.06.097","article-title":"Lobectomy versus stereotactic body radiotherapy in healthy octogenarians with stage I lung cancer","volume":"111","author":"Razi SS","year":"2021","unstructured":"Razi SS, Kodia K, Alnajar A, Block MI, Tarrazzi F, Nguyen D, Villamizar N. Lobectomy versus stereotactic body radiotherapy in healthy octogenarians with stage I lung cancer. Ann Thorac Surg. 2021, 111:1659-65. 10.1016\/j.athoracsur.2020.06.097","journal-title":"Ann Thorac Surg"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-20-2367","article-title":"Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size \u2264 5 cm: a propensity score matching analysis","volume":"12","author":"Dong B","year":"2020","unstructured":"Dong B, Zhu X, Jin J, et al.. Comparison of the outcomes of sublobar resection and stereotactic body radiotherapy for stage T1-2N0M0 non-small cell lung cancer with tumor size \u2264 5 cm: a propensity score matching analysis. J Thorac Dis. 2020, 12:5934-54. 10.21037\/jtd-20-2367","journal-title":"J Thorac Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.585709","article-title":"Video-assisted thoracoscopic lobectomy versus stereotactic body radiotherapy treatment for early-stage non-small cell lung cancer: a propensity score-matching analysis","volume":"10","author":"Dong B","year":"2020","unstructured":"Dong B, Zhu X, Shu Z, Ji Y, Lu F, Wang J, Chen M. Video-assisted thoracoscopic lobectomy versus stereotactic body radiotherapy treatment for early-stage non-small cell lung cancer: a propensity score-matching analysis. Front Oncol. 2020, 10:585709. 10.3389\/fonc.2020.585709","journal-title":"Front Oncol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2019.11.132","article-title":"Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a National Cancer Database study","volume":"160","author":"Wu J","year":"2020","unstructured":"Wu J, Bai HX, Chan L, Su C, Zhang PJ, Yang L, Zhang Z. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: a National Cancer Database study. J Thorac Cardiovasc Surg. 2020, 160:1350-1357.e11. 10.1016\/j.jtcvs.2019.11.132","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref32","article-title":"Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection","volume":"35","author":"Kastelijn E","year":"2015","unstructured":"Kastelijn E, El Sharouni S, Hofman F, et al.. Clinical outcomes in early-stage NSCLC treated with stereotactic body radiotherapy versus surgical resection. Anticancer Res. 2015, 35:5607-14.","journal-title":"Anticancer Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyw058","article-title":"Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)","volume":"46","author":"Eba J","year":"2016","unstructured":"Eba J, Nakamura K, Mizusawa J, et al.. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). Jpn J Clin Oncol. 2016, 46:748-53. 10.1093\/jjco\/hyw058","journal-title":"Jpn J Clin Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-0858-y","article-title":"Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis","volume":"19","author":"Lin Q","year":"2019","unstructured":"Lin Q, Sun X, Zhou N, Wang Z, Xu Y, Wang Y. Outcomes of stereotactic body radiotherapy versus lobectomy for stage I non-small cell lung cancer: a propensity score matching analysis. BMC Pulm Med. 2019, 19:98. 10.1186\/s12890-019-0858-y","journal-title":"BMC Pulm Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000680","article-title":"Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy","volume":"10","author":"Puri V","year":"2015","unstructured":"Puri V, Crabtree TD, Bell JM, et al.. Treatment outcomes in stage I lung cancer: a comparison of surgery and stereotactic body radiation therapy. J Thorac Oncol. 2015, 10:1776-84. 10.1097\/JTO.0000000000000680","journal-title":"J Thorac Oncol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2017.07.048","article-title":"Stereotactic body radiation therapy versus surgery for early lung cancer among US\u00a0veterans","volume":"105","author":"Bryant AK","year":"2018","unstructured":"Bryant AK, Mundt RC, Sandhu AP, et al.. Stereotactic body radiation therapy versus surgery for early lung cancer among US\u00a0veterans. Ann Thorac Surg. 2018, 105:425-31. 10.1016\/j.athoracsur.2017.07.048","journal-title":"Ann Thorac Surg"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2019.04.015","article-title":"Comparison of the efficacy of stereotactic body radiotherapy versus surgical treatment for early-stage non-small cell lung cancer after propensity score matching","volume":"12","author":"Dong B","year":"2019","unstructured":"Dong B, Wang J, Xu Y, et al.. Comparison of the efficacy of stereotactic body radiotherapy versus surgical treatment for early-stage non-small cell lung cancer after propensity score matching. Transl Oncol. 2019, 12:1032-7. 10.1016\/j.tranon.2019.04.015","journal-title":"Transl Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-017-1536-4","article-title":"Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis","volume":"47","author":"Miyazaki T","year":"2017","unstructured":"Miyazaki T, Yamazaki T, Nakamura D, et al.. Surgery or stereotactic body radiotherapy for elderly stage I lung cancer? A propensity score matching analysis. Surg Today. 2017, 47:1476-83. 10.1007\/s00595-017-1536-4","journal-title":"Surg Today"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.2147\/LCTT.S166320","article-title":"1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT","volume":"9","author":"Albano D","year":"2018","unstructured":"Albano D, Bilfinger T, Nemesure B. 1-, 3-, and 5-year survival among early-stage lung cancer patients treated with lobectomy vs SBRT. Lung Cancer (Auckl). 2018, 9:65-71. 10.2147\/LCTT.S166320","journal-title":"Lung Cancer (Auckl)"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2017.07.065","article-title":"Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer","volume":"155","author":"Cornwell LD","year":"2018","unstructured":"Cornwell LD, Echeverria AE, Samuelian J, et al.. Video-assisted thoracoscopic lobectomy is associated with greater recurrence-free survival than stereotactic body radiotherapy for clinical stage I lung cancer. J Thorac Cardiovasc Surg. 2018, 155:395-402. 10.1016\/j.jtcvs.2017.07.065","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000600","article-title":"Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer","volume":"10","author":"Ezer N","year":"2015","unstructured":"Ezer N, Veluswamy RR, Mhango G, Rosenzweig KE, Powell CA, Wisnivesky JP. Outcomes after stereotactic body radiotherapy versus limited resection in older patients with early-stage lung cancer. J Thorac Oncol. 2015, 10:1201-6. 10.1097\/JTO.0000000000000600","journal-title":"J Thorac Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2015.01.005","article-title":"Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis","volume":"87","author":"Mokhles S","year":"2015","unstructured":"Mokhles S, Verstegen N, Maat AP, et al.. Comparison of clinical outcome of stage I non-small cell lung cancer treated surgically or with stereotactic radiotherapy: results from propensity score analysis. Lung Cancer. 2015, 87:283-9. 10.1016\/j.lungcan.2015.01.005","journal-title":"Lung Cancer"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2015.05.002","article-title":"Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults","volume":"6","author":"Smith BD","year":"2015","unstructured":"Smith BD, Jiang J, Chang JY, et al.. Cost-effectiveness of stereotactic radiation, sublobar resection, and lobectomy for early non-small cell lung cancers in older adults. J Geriatr Oncol. 2015, 6:324-31. 10.1016\/j.jgo.2015.05.002","journal-title":"J Geriatr Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000483","article-title":"Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC","volume":"10","author":"van den Berg LL","year":"2015","unstructured":"van den Berg LL, Klinkenberg TJ, Groen HJ, Widder J. Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC. J Thorac Oncol. 2015, 10:826-31. 10.1097\/JTO.0000000000000483","journal-title":"J Thorac Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005723","article-title":"A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly","volume":"95","author":"Wang P","year":"2016","unstructured":"Wang P, Zhang D, Guo XG, et al.. A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly. Medicine (Baltimore). 2016, 95:e5723. 10.1097\/MD.0000000000005723","journal-title":"Medicine (Baltimore)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i3570","article-title":"Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis","volume":"354","author":"Paul S","year":"2016","unstructured":"Paul S, Lee PC, Mao J, Isaacs AJ, Sedrakyan A. Long term survival with stereotactic ablative radiotherapy (SABR) versus thoracoscopic sublobar lung resection in elderly people: national population based study with propensity matched comparative analysis. BMJ. 2016, 354:i3570. 10.1136\/bmj.i3570","journal-title":"BMJ"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2016.03.060","article-title":"Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer","volume":"152","author":"Rosen JE","year":"2016","unstructured":"Rosen JE, Salazar MC, Wang Z, et al.. Lobectomy versus stereotactic body radiotherapy in healthy patients with stage I lung cancer. J Thorac Cardiovasc Surg. 2016, 152:44-54.e9. 10.1016\/j.jtcvs.2016.03.060","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2017.02.065","article-title":"A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer","volume":"154","author":"Yerokun BA","year":"2017","unstructured":"Yerokun BA, Yang CJ, Gulack BC, et al.. A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2017, 154:675-686.e4. 10.1016\/j.jtcvs.2017.02.065","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang JY","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, et al.. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015, 16:630-7. 10.1016\/S1470-2045(15)70168-3","journal-title":"Lancet Oncol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.09.1952","article-title":"Improved survival of stage i non-small cell lung cancer: a VA Central Cancer Registry analysis","volume":"12","author":"Boyer MJ","year":"2017","unstructured":"Boyer MJ, Williams CD, Harpole DH, Onaitis MW, Kelley MJ, Salama JK. Improved survival of stage i non-small cell lung cancer: a VA Central Cancer Registry analysis. J Thorac Oncol. 2017, 12:1814-23. 10.1016\/j.jtho.2017.09.1952","journal-title":"J Thorac Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2014.556","article-title":"Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly","volume":"149","author":"Shirvani SM","year":"2014","unstructured":"Shirvani SM, Jiang J, Chang JY, et al.. Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderly. JAMA Surg. 2014, 149:1244-53. 10.1001\/jamasurg.2014.556","journal-title":"JAMA Surg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2014.11.009","article-title":"Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer","volume":"99","author":"Hamaji M","year":"2015","unstructured":"Hamaji M, Chen F, Matsuo Y, et al.. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer. Ann Thorac Surg. 2015, 99:1122-9. 10.1016\/j.athoracsur.2014.11.009","journal-title":"Ann Thorac Surg"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31827ce361","article-title":"Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer","volume":"8","author":"Robinson CG","year":"2013","unstructured":"Robinson CG, DeWees TA, El Naqa IM, et al.. Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. J Thorac Oncol. 2013, 8:192-201. 10.1097\/JTO.0b013e31827ce361","journal-title":"J Thorac Oncol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28100","article-title":"Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery","volume":"119","author":"Varlotto J","year":"2013","unstructured":"Varlotto J, Fakiris A, Flickinger J, et al.. Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery. Cancer. 2013, 119:2683-91. 10.1002\/cncr.28100","journal-title":"Cancer"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2013.11.057","article-title":"Analysis of first recurrence and survival in patients with stage I\u00a0non-small cell lung cancer treated with surgical resection or\u00a0stereotactic radiation therapy","volume":"147","author":"Crabtree TD","year":"2014","unstructured":"Crabtree TD, Puri V, Robinson C, et al.. Analysis of first recurrence and survival in patients with stage I\u00a0non-small cell lung cancer treated with surgical resection or\u00a0stereotactic radiation therapy. J Thorac Cardiovasc Surg. 2014, 147:1183-1191; discussion 1191-2. 10.1016\/j.jtcvs.2013.11.057","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.07.2354","article-title":"Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly","volume":"84","author":"Shirvani SM","year":"2012","unstructured":"Shirvani SM, Jiang J, Chang JY, et al.. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012, 84:1060-70. 10.1016\/j.ijrobp.2012.07.2354","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.06.029","article-title":"Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery","volume":"101","author":"Palma D","year":"2011","unstructured":"Palma D, Visser O, Lagerwaard FJ, Belderbos J, Slotman B, Senan S. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol. 2011, 101:240-4. 10.1016\/j.radonc.2011.06.029","journal-title":"Radiother Oncol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0928","article-title":"Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer","volume":"28","author":"Grills IS","year":"2010","unstructured":"Grills IS, Mangona VS, Welsh R, et al.. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010, 28:928-35. 10.1200\/JCO.2009.25.0928","journal-title":"J Clin Oncol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.12.054","article-title":"Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer","volume":"140","author":"Crabtree TD","year":"2010","unstructured":"Crabtree TD, Denlinger CE, Meyers BF, et al.. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2010, 140:377-86. 10.1016\/j.jtcvs.2009.12.054","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2018.08.075","article-title":"A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer","volume":"157","author":"Cao C","year":"2019","unstructured":"Cao C, Wang D, Chung C, Tian D, Rimner A, Huang J, Jones DR. A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019, 157:362-373.e8. 10.1016\/j.jtcvs.2018.08.075","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/369987-surgery-versus-stereotactic-body-radiotherapy-for-early-stage-non-small-cell-lung-cancer-nsclc-a-comprehensive-review-of-survival-and-local-control-outcomes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T09:01:52Z","timestamp":1747731712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/369987-surgery-versus-stereotactic-body-radiotherapy-for-early-stage-non-small-cell-lung-cancer-nsclc-a-comprehensive-review-of-survival-and-local-control-outcomes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.84440","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,19]]}}}